Cellular immune defects to Epstein-Barr virus-determined antigens in young males
- PMID: 6171337
Cellular immune defects to Epstein-Barr virus-determined antigens in young males
Abstract
Three males with the X-linked lymphoproliferative syndrome (XLP) with hypo- or agammaglobulinemia following Epstein-Barr virus (EBV) infection and two males with the chronic mononucleosis syndrome were investigated for immune responses to EBV-determined antigens. Males with XLP showed profound cellular immune defects. Markedly diminished responses of natural killer cell and interferon-activated killer cell activities and impaired leukocyte migration inhibition responses to phytohemagglutinin were determined in patients with XLP. The two patients with chronic mononucleosis showed less severe defects. All patients showed partial or complete impairment of their EBV-specific immune responses as measured by leukocyte migration inhibition. EBV-specific antibodies were markedly diminished against EBV-associated nuclear antigen, early antigen, and viral capsid antigen in males with XLP. In contrast, patients with chronic mononucleosis had elevated antibodies to most EBV-specific antigens. Individuals with life-threatening EBV-induced lymphoproliferative disorders may exhibit multiple defective immune mechanisms against the virus.
Similar articles
-
X-linked lymphoproliferative syndrome.Immunodefic Rev. 1989;1(4):325-47. Immunodefic Rev. 1989. PMID: 2561059 Review.
-
Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.AIDS Res. 1986 Dec;2 Suppl 1:S177-81. AIDS Res. 1986. PMID: 2435295
-
Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.Q J Med. 1986 Feb;58(226):111-21. Q J Med. 1986. PMID: 3012622
-
Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.J Immunol. 1982 Dec;129(6):2532-5. J Immunol. 1982. PMID: 6292290
-
[X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].Monatsschr Kinderheilkd. 1993 Mar;141(3):201-6. Monatsschr Kinderheilkd. 1993. PMID: 8386321 Review. German.
Cited by
-
The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease.Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):11966-71. doi: 10.1073/pnas.0905691106. Epub 2009 Jul 1. Proc Natl Acad Sci U S A. 2009. PMID: 19570996 Free PMC article.
-
Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.J Clin Immunol. 1984 Sep;4(5):369-82. doi: 10.1007/BF00917140. J Clin Immunol. 1984. PMID: 6092413 Review.
-
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.Clin Exp Immunol. 1983 Aug;53(2):257-71. Clin Exp Immunol. 1983. PMID: 6309441 Free PMC article. Review. No abstract available.
-
Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue.J Clin Pathol. 1990 Mar;43(3):220-3. doi: 10.1136/jcp.43.3.220. J Clin Pathol. 1990. PMID: 2159030 Free PMC article.
-
Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity.Clin Exp Immunol. 1986 Feb;63(2):280-9. Clin Exp Immunol. 1986. PMID: 3009061 Free PMC article.